AnalystsBenjamin HaynorBenjamin Haynor's Stock Forecasts
AnalystsBenjamin Haynor
Analyst Ranking
Top 39%
#1989 out of 5209 analysts
Average Return
+4.72%
Win Rate
38%5 out of 13
Risk vs Reward
Poor
Good
Benjamin Haynor's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Viasat IncVSAT | +131.87% | $12.77 | $29.61 | 2024-09-19 - 2025-09-19 | Strong Buy |
Surmodics IncSRDX | +97.46% | $27.55 | $54.40 | 2017-06-26 - 2018-06-27 | Strong Buy |
Profound Medical CorpPROF | +59.49% | $4.69 | $7.48 | 2025-04-22 - 2026-03-04 | Strong Buy |
Strata Critical Medical IncSRTA | +16.99% | $4.18 | $4.89 | 2025-12-01 - 2026-03-04 | Strong Buy |
Femasys IncFEMY | +3.02% | $0.53 | $0.55 | 2026-03-02 - 2026-03-04 | Strong Buy |
Benjamin Haynor Analyst Color
Get additional color on Benjamin Haynor's coverage of popular stocks
Benjamin Haynor's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Femasys IncFEMY | 1 | Strong Buy | $1.50 | +175.23% | Initiates Coverage On | 2 days ago |
Profound Medical CorpPROF | 2 | Strong Buy | $12.00 | +60.43% | Maintains | 2 months ago |
Strata Critical Medical IncSRTA | 1 | Strong Buy | $8.00 | +63.60% | Assumes | 3 months ago |
Infusystem Holdings IncINFU | 1 | Strong Buy | $15.00 | +56.25% | Assumes | 5 months ago |
Electromed IncELMD | 1 | Strong Buy | $36.00 | +48.21% | Assumes | 6 months ago |
Viasat IncVSAT | 5 | Strong Buy | $19.00 | N/A | Maintains | a year ago |
Cognyte Software LtdCGNT | 2 | Hold | N/A | N/A | Downgrades | 8 years ago |
Dariohealth CorpDRIO | 1 | Strong Buy | $1,400.00 | N/A | Initiates Coverage On | 9 years ago |
Surmodics IncSRDX | 1 | Strong Buy | $43.50 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.